PRE-EMPT (PREgnancy Evidence, Monitoring, Partnerships and Treatment)


Reporting Organization:PRE-EMPT
Total Budget ($CAD):$ 33,863,873
Timeframe: November 15, 2011 - June 14, 2019
Status: Implementation
Contact Information: Marianne Vidler
[email protected]

Partner & Funder Profiles


Reporting Organization


PRE-EMPT

Participating Organizations


  • Academia and Research

    • MAGnesium Sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)
    • PRECISE (PREgnancy Care Integrating translational Science, Everywhere)
    • Place Alerts Lab (PALs)
    • The Canadian Perinatal Network (CPN)
  • Multilateral Organizations

    • Global Pregnancy Collaboration (CoLab)

Funders (Total Budget Contribution)


  • NGOs

    • Bill and Melinda Gates Foundation (100.00%)
Return to top

Location


Country - Total Budget Allocation


India - $ 11,290,215.09 (33.34%)

Mozambique - $ 11,286,828.70 (33.33%)

Pakistan - $ 11,286,828.70 (33.33%)

Return to top

Areas of Focus


Health - Total Budget Allocation


Reproductive Health & Rights incl. Maternal Health (50 %)

Health Systems, Training & Infrastructure (20 %)

Health Promotion & Education (10 %)

Primary Health Care (10 %)

Secondary/Tertiary Health Care (10 %)

Return to top

Description


We are a global consortium of researchers, innovators, & advocates who work in diverse areas ranging from clinical medicine, data & social science, epidemiology, biobanking, medical anthropology, & health policy with the aim of improving maternal health.

Return to top

Target Population


Gender and age: Adult women
Descriptors: Rural
Total Direct Population: 69,350
Return to top

Outputs


295 Abstracts and papers published
7 Annual reports produced
Return to top

Results & Indicators


Expected Results


Unspecified

Achieved Results


Objective 1: Prevention (the CAP or the Calcium and Pre-eclampsia Trial) – found that low-dose calcium probably reduces risk of recurrent
pre-eclampsia and pregnancy loss

Objective 2: Monitoring (miniPIERS and PIERS On the Move) – Accurate time-of-disease risk stratification, detected 2081 hypertensive pregnant women

Objective 3: Treatment (Gynuity Oral Antihypertensive Project and the Community Level Interventions for Pre-eclampsia Trial)
Detected 894 women with severe pregnancy hypertension and found Nifedipine, Labetalol and Methyldopa largely equivalent.

Objective 4: Global Pregnancy Collaboration – 24 Centres providing samples, access to >450,000 samples

Objective 5: Knowledge Translation – 23,106 community engagement sessions during CLIP Trials and 589 health workers trained

Indicators


MNCH-related indicators
  • # of health facilities equipped with maternal and newborn child health, or sexual and reproductive health equipment
  • # of health facilities that provide gender-responsive family-planning services
  • % of total population living within 5 km to a functioning health facility
  • %/total households and institutions (schools/clinics) with access to adequate sanitation and hygiene facilities
  • %/total households with access to a safe water supply
  • %/total of health workers (male/female) trained and using their learned skills
  • %/total of mothers, and %/total of babies, who received postnatal care within two days of childbirth
  • %/total of women aged 15-49 years with anemia
  • %/total of women attended at least four times during pregnancy by any provider for reasons related to the pregnancy
  • Relevant data collection on vital statistics (birth, deaths, and causes of deaths) are collected
  • Women’s groups/CSOs participating in the development of strategies and/or projects
SDG Goal 1. End poverty in all its forms everywhere
  • SDG 1.4.1 Proportion of population living in households with access to basic services
SDG Goal 3. Ensure healthy lives and promote well-being for all at all ages
  • SDG 3.1.1 Maternal mortality ratio
  • SDG 3.1.2 Proportion of births attended by skilled health personnel
  • SDG 3.4.1 Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease
  • SDG 3.9.2 Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (exposure to unsafe Water, Sanitation and Hygiene for All (WASH) services)
  • SDG 3.b.3 Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis
  • SDG 3.c.1 Health worker density and distribution
Return to top
Return to top

Sub Projects


Return to top
Icon